|
15
|
98
|
3to4B |
Structure of mouse valpha14vbeta2-mousecd1d-alpha-galactosylceramide |
|
70
|
293
|
3tn0A |
Structure of mouse va14vb8.2nkt tcr-mouse cd1d-a-c-galactosylceramide complex |
|
73
|
275
|
3to2A |
Structure of hla-a*0201 complexed with peptide md3-c9 derived from a clustering region of restricted cytotoxic t lymphocyte epitope from sars-cov m protein |
|
15
|
100
|
3to2B |
Structure of hla-a*0201 complexed with peptide md3-c9 derived from a clustering region of restricted cytotoxic t lymphocyte epitope from sars-cov m protein |
|
14
|
100
|
3tlrA |
Crystal structure of the tetrameric beta-2 microglobulin dimc20 mutant |
|
50
|
242
|
3tn0D |
Structure of mouse va14vb8.2nkt tcr-mouse cd1d-a-c-galactosylceramide complex |
|
15
|
99
|
3tbtB |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4s) |
|
76
|
273
|
3ta3A |
Structure of the mouse cd1d-glc-dag-s2-inkt tcr complex |
|
15
|
99
|
3tidB |
Crystal structure of the lcmv derived peptide gp34 in complex with the murine mhc class i h-2 kb |
|
64
|
275
|
3tbtA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4s) |
|
14
|
96
|
3ta3B |
Structure of the mouse cd1d-glc-dag-s2-inkt tcr complex |
|
13
|
99
|
3tbyB |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4f) |
|
15
|
99
|
3tbvB |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g,v3p,y4a) |
|
63
|
274
|
3tbwA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g, v3p, y4s) |
|
64
|
275
|
3tbsA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex the with lcmv-derived gp33 altered peptide ligand (v3p,y4a) |
|
68
|
277
|
3tidA |
Crystal structure of the lcmv derived peptide gp34 in complex with the murine mhc class i h-2 kb |
|
64
|
275
|
3tbyA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (v3p, y4f) |
|
67
|
276
|
3tbvA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g,v3p,y4a) |
|
15
|
99
|
3tieB |
Crystal structure of the vaccinia derived peptide a11r in complex with the murine mhc class i h-2 kb |
|
14
|
99
|
3tbwB |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with the lcmv-derived gp33 altered peptide ligand (a2g, v3p, y4s) |
|
14
|
99
|
3tbsB |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex the with lcmv-derived gp33 altered peptide ligand (v3p,y4a) |
|
63
|
239
|
3ta3D |
Structure of the mouse cd1d-glc-dag-s2-inkt tcr complex |
|
73
|
277
|
3tieA |
Crystal structure of the vaccinia derived peptide a11r in complex with the murine mhc class i h-2 kb |
|
15
|
99
|
3t8xB |
Crystal structure of human cd1b in complex with synthetic antigenic diacylsulfoglycolipid sgl12 and endogenous spacer |
|
16
|
99
|
3t1fB |
Crystal structure of the mouse cd1d-glc-dag-s2 complex |
|
76
|
273
|
3t1fA |
Crystal structure of the mouse cd1d-glc-dag-s2 complex |
|
72
|
275
|
3t8xA |
Crystal structure of human cd1b in complex with synthetic antigenic diacylsulfoglycolipid sgl12 and endogenous spacer |
|
41
|
245
|
3t0eD |
Crystal structure of a complete ternary complex of t cell receptor, peptide-mhc and cd4 |
|
51
|
219
|
3t77A |
S25-2- a(2-4)kdo disaccharide complex |
|
39
|
218
|
3t0eB |
Crystal structure of a complete ternary complex of t cell receptor, peptide-mhc and cd4 |
|
75
|
276
|
3skoA |
Crystal structure of the hla-b8-a66-flr, mutant a66 of the hla b8 |
|
52
|
277
|
3sjvA |
Crystal structure of the rl42 tcr in complex with hla-b8-flr |
|
14
|
99
|
3skmB |
Crystal structure of the hla-b8flrgrayvl, mutant g8v of the flr peptide |
|
8
|
99
|
3sjvB |
Crystal structure of the rl42 tcr in complex with hla-b8-flr |
|
81
|
276
|
3spvA |
Crystal structure of a peptide-hla complex |
|
39
|
209
|
3sgkA |
Unique carbohydrate/carbohydrate interactions are required for high affinity binding of fcgiii and antibodies lacking core fucose |
|
14
|
99
|
3spvB |
Crystal structure of a peptide-hla complex |
|
15
|
100
|
3skoB |
Crystal structure of the hla-b8-a66-flr, mutant a66 of the hla b8 |
|
80
|
276
|
3skmA |
Crystal structure of the hla-b8flrgrayvl, mutant g8v of the flr peptide |
|
80
|
290
|
3sdaA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-galactosylceramide |
|
13
|
99
|
3scmB |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-isoglobotrihexosylceramide |
|
41
|
219
|
3sgjA |
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between fcgiii and antibodies lacking core fucose |
|
75
|
290
|
3sddA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-lactosylceramide |
|
11
|
99
|
3sdaB |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-galactosylceramide |
|
76
|
289
|
3sdcA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-globotrihexosylceramide |
|
68
|
275
|
3sdxA |
Crystal structure of human autoreactive-valpha24 nkt tcr in complex with cd1d-beta-galactosylceramide |
|
12
|
99
|
3sddB |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-beta-lactosylceramide |
|
78
|
289
|
3scmA |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-isoglobotrihexosylceramide |
|
12
|
99
|
3sdcB |
Crystal structure of autoreactive-valpha14-vbeta6 nkt tcr in complex with cd1d-globotrihexosylceramide |
|
14
|
97
|
3sdxB |
Crystal structure of human autoreactive-valpha24 nkt tcr in complex with cd1d-beta-galactosylceramide |
